Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
Ann Intern Med
    September 2025
  1. ANDREWS RA, Erickson SM, Goldman JM, Moyer DV, et al
    Deja Flu All Over Again: The Risk for Overwhelm of the U.S. Health Care System by Vaccine-Preventable and Modifiable Diseases.
    Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-25-03999.
    >> Share

  2. LAINE C, Turner BJ, Qaseem A, Moyer DV, et al
    Vaccines: Decision Making Amid Conflicting Recommendations.
    Ann Intern Med. 2025 Sep 16. doi: 10.7326/ANNALS-25-04054.
    >> Share

    July 2025
  3. KOBAYASHI M, Loehr J, Caine VA, Cohen AL, et al
    New Pneumococcal Vaccine Recommendation for U.S. Adults Aged 50 Years and Older-Promise and Challenges.
    Ann Intern Med. 2025 Jul 22. doi: 10.7326/ANNALS-25-01178.
    >> Share


  4. Correction: Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood.
    Ann Intern Med. 2025 Jul 17. doi: 10.7326/ANNALS-25-03233.
    >> Share


  5. Summary for Patients: Aluminum in Vaccines and the Risk for Childhood Disease.
    Ann Intern Med. 2025 Jul 15. doi: 10.7326/ANNALS-25-00997.
    >> Share

  6. ANDERSSON NW, Bech Svalgaard I, Hoffmann SS, Hviid A, et al
    Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood : A Nationwide Cohort Study.
    Ann Intern Med. 2025 Jul 15. doi: 10.7326/ANNALS-25-00997.
    >> Share

    June 2025
  7. GOLDMAN JM, Fryhofer SA
    Preserving Scientific Integrity in Vaccine Policy: The Role of, and Risk to, the CDC's Advisory Committee on Immunization Practices.
    Ann Intern Med. 2025 Jun 24. doi: 10.7326/ANNALS-25-02806.
    >> Share

    May 2025
  8. JACOBS JW, Booth GS, Lewis-Newby M, Saifee NH, et al
    Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025.
    Ann Intern Med. 2025 May 13. doi: 10.7326/ANNALS-25-00815.
    >> Share

    April 2025
  9. BLUMENTHAL KG, Phillips EJ
    Chronic Urticaria Following HIV mRNA Vaccines: A Challenging Signal in Need of Mechanistic Insight.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-25-01102.
    >> Share

  10. RIDDLER SA, Moodie Z, Clark J, Yen C, et al
    High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701.
    >> Share

  11. BILINSKI A, Emanuel N, Ciaranello A
    Sins of Omission: Model-Based Estimates of the Health Effects of Excluding Pregnant Participants From Randomized Controlled Trials.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-00689.
    >> Share

  12. DACSO CC
    Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to separate administration for immune responses in adults aged >/=50 y.
    Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00904.
    >> Share

    February 2025
  13. IOANNOU GN, Berry K, Rajeevan N, Li Y, et al
    Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015.
    >> Share

    December 2024
  14. VASSILOPOULOS S, Mylonakis E
    After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
    Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887.
    >> Share

    November 2024
  15. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2024 Nov 26. doi: 10.7326/M24-0421.
    >> Share

    July 2024
  16. KAUFFMAN RP
    mRNA COVID-19 vaccination during pregnancy was not linked to increased adverse neonatal outcomes.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00621.
    >> Share

  17. FUJIEDA T, Tanimoto T
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990-991.
    >> Share

  18. SCHATTNER A
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990.
    >> Share

  19. TENFORDE MW, Dawood FS
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:991.
    >> Share

    June 2024
  20. DUTCHER EG, Epel ES, Mason AE, Hecht FM, et al
    COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M23-2956.
    >> Share

    May 2024

  21. Notice of Retraction: Measles, Mumps, Rubella Vaccination and Autism.
    Ann Intern Med. 2024 May 21. doi: 10.7326/ANNALS-24-00530.
    >> Share

    April 2024
  22. COSCHI CH, Dodbiba L, Guerry D
    Oncology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
    >> Share

    March 2024
  23. WELLS CR, Pandey A, Moghadas SM, Fitzpatrick MC, et al
    Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451.
    >> Share

  24. HUITS R, Grubaugh ND, Libman M, Hamer DH, et al
    Resurgence of Dengue in the Era of Genomic Surveillance and Vaccines.
    Ann Intern Med. 2024 Mar 19. doi: 10.7326/M24-0496.
    >> Share

  25. JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
    Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation Trial.
    Ann Intern Med. 2024 Mar 19. doi: 10.7326/M23-2638.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016